Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Anakinra and its rapidly expanding role in management of nonarthritic systemic disorders.

Kapoor S.

J Rheumatol. 2009 Feb;36(2):446; author reply 447. doi: 10.3899/jrheum.080802. No abstract available.

PMID:
19208574
[PubMed - indexed for MEDLINE]
2.

Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.

Ikonomidis I, Tzortzis S, Lekakis J, Paraskevaidis I, Andreadou I, Nikolaou M, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos P, Kremastinos DT.

Heart. 2009 Sep;95(18):1502-7. doi: 10.1136/hrt.2009.168971. Epub 2009 May 28.

PMID:
19482847
[PubMed - indexed for MEDLINE]
3.

[Remission--therapy goal in rheumatoid arthritis].

[No authors listed]

Z Rheumatol. 2007 Feb;66(1):2 p following 87. German. No abstract available.

PMID:
17896425
[PubMed - indexed for MEDLINE]
4.

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.

Kalliolias GD, Liossis SN.

Expert Opin Investig Drugs. 2008 Mar;17(3):349-59. doi: 10.1517/13543784.17.3.349 . Review.

PMID:
18321234
[PubMed - indexed for MEDLINE]
5.

[Interleukin-1 inhibitors: a new alternative for the treatment of rheumatoid polyarthritis].

Gabay C.

Rev Med Suisse Romande. 2000 Jun;120(6):529-33. Review. French. No abstract available.

PMID:
11014098
[PubMed - indexed for MEDLINE]
6.

[Indications of anakinra].

Chauffier K, London J, Beaudouin C, Fautrel B.

Presse Med. 2009 May;38(5):799-807. doi: 10.1016/j.lpm.2009.01.012. Epub 2009 Mar 10. French.

PMID:
19278814
[PubMed - indexed for MEDLINE]
7.

Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al.

Schiff MH.

Arthritis Rheum. 2005 Jan;52(1):364-5; author reply 365. No abstract available.

PMID:
15641081
[PubMed - indexed for MEDLINE]
Free Article
8.

Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.

Botsios C, Sfriso P, Ostuni PA, Todesco S, Punzi L.

Rheumatology (Oxford). 2007 Jun;46(6):1042-3. Epub 2007 Apr 19. No abstract available.

PMID:
17449489
[PubMed - indexed for MEDLINE]
Free Article
9.

Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.

[No authors listed]

Am J Health Syst Pharm. 2002 Feb 1;59(3):225-6. No abstract available.

PMID:
11862629
[PubMed - indexed for MEDLINE]
10.

[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 4. Interleukin-1 inhibitor].

Yamasaki S, Kawakami A.

Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2985-90. Review. Japanese. No abstract available.

PMID:
22175142
[PubMed - indexed for MEDLINE]
11.

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.

Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J.

J Clin Rheumatol. 2009 Jun;15(4):161-4. doi: 10.1097/RHU.0b013e3181a4f459.

PMID:
19363453
[PubMed - indexed for MEDLINE]
12.

Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.

Guignard S, Dien G, Dougados M.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):758-9.

PMID:
18078628
[PubMed - indexed for MEDLINE]
13.

IL-1 inhibition with anakinra in a patient with refractory gout.

Singh D, Huston KK.

J Clin Rheumatol. 2009 Oct;15(7):366. doi: 10.1097/RHU.0b013e3181be2423. No abstract available.

PMID:
20009976
[PubMed - indexed for MEDLINE]
14.

Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.

Merlin E, Berthomieu L, Dauphin C, St├ęphan JL.

Pediatr Cardiol. 2011 Aug;32(6):862-3. doi: 10.1007/s00246-011-0009-6. No abstract available.

PMID:
21544583
[PubMed - indexed for MEDLINE]
15.

Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).

Ohlsson V, Baildam E, Foster H, Jandial S, Pain C, Strike H, Ramanan AV.

Rheumatology (Oxford). 2008 Apr;47(4):555-6. doi: 10.1093/rheumatology/ken030. Epub 2008 Mar 5. No abstract available.

PMID:
18321945
[PubMed - indexed for MEDLINE]
Free Article
16.

Anakinra (Kineret) for rheumatoid arthritis.

[No authors listed]

Med Lett Drugs Ther. 2002 Feb 18;44(1124):18-9. No abstract available.

PMID:
11856953
[PubMed - indexed for MEDLINE]
17.

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P.

Br J Dermatol. 2009 Nov;161(5):1199-201. doi: 10.1111/j.1365-2133.2009.09404.x. Epub 2009 Aug 10.

PMID:
19673875
[PubMed - indexed for MEDLINE]
18.

Case of anakinra as a steroid-sparing agent for gout inflammation.

Gratton SB, Scalapino KJ, Fye KH.

Arthritis Rheum. 2009 Sep 15;61(9):1268-70. doi: 10.1002/art.24694. No abstract available.

PMID:
19714614
[PubMed - indexed for MEDLINE]
Free Article
19.

Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease.

Woo P.

Ann Rheum Dis. 2008 Mar;67(3):281-2. doi: 10.1136/ard.2007.082859. No abstract available.

PMID:
18292104
[PubMed - indexed for MEDLINE]
20.

A case of macrophage activation syndrome successfully treated with anakinra.

Kelly A, Ramanan AV.

Nat Clin Pract Rheumatol. 2008 Nov;4(11):615-20. doi: 10.1038/ncprheum0919. Epub 2008 Sep 30.

PMID:
18825135
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk